Dogwood Therapeutics, Inc. has announced the dosing of the first patient in its Phase 2b clinical trial, HALT-CINP, which studies Halneuron® as a treatment for chemotherapy-induced neuropathic pain.

Dogwood Therapeutics, Inc. (Nasdaq: DWTX) ("Dogwood” or the "Company”), a development-stage biopharmaceutical company focused on advancing first-in-class, non-opioid, treatments for chronic and acute ...

Q4 2024 Earnings Call Transcript March 20, 2025 Operator: Hello, everyone, and thank you for joining 111’s Conference Call ...

Chairman of the Board, Chief Executive Officer, Co-Founder; 111 Inc. Luke Chen; Chief Financial Officer; 111 Inc. Gang Yu; Executive Chairman, Co-Fou ...

Thank you for standing by and welcome to the T1 Energy fourth-quarter 2024 earnings conference call. (Operator Instructions) Thank you. I'd now like to turn the call over to Jeffrey Spittel, EVP ...

Q4 2024 Earnings Conference Call March 17, 2025 8:00 AM ETCompany ParticipantsJeffrey Spittel - VP, IRDaniel Barcelo - ...

IMA Life hasn't even finished construction on its new 80,000-square-foot Tonawanda facility, but the manufacturer is already ...

Pope Francis has approved a new three-year reform process for the Catholic Church, sending a strong signal he plans to continue in the post despite spending a month in hospital battling pneumonia.

Marvel Phase 5's time grows short ... to start filming in March 2024 and surprisingly wrapped production just three months later. Stan's Bucky Barnes, Dreyfus' Valentina Allegra de Fontaine ...